Your email has been successfully added to our mailing list.

×
0.00735294117647059 -0.00735294117647059 -0.0183823529411766 0.00735294117647059 -0.0441176470588236 -0.0313235294117647 0.0110294117647058 -0.0330882352941176
Stock impact report

Celsion completes OVATION study and provides update on advanced stage III and IV Ovarian Cancer; shares ahead 34% premarket [Seeking Alpha]

Celsion Corporation (CLSN) 
Last celsion corporation earnings: 11/14 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.celsion.com/investor-relations
Company Research Source: Seeking Alpha
Celsion Corporation (NASDAQ: CLSN ) provides an update on its Phase Ib dose escalating clinical trial (the OVATION Study) combining GEN-1 with neoadjuvant chemotherapy for the treatment of patients with Stage III and IV ovarian cancer followed by interval debulking surgery. Enrollment got complete in the OVATION study. The clinical findings from the study enrolling 14 patients are as follows: 86% Objective Response Rate (ORR) in Phase IB dose escalating study. 100% ORR and 100% R0 (Margin Negative) surgical resection rate at highest dose cohort. Final translational research data is being collected and will be available in Q3 for evaluation. Previous research findings from the first four patient cohorts are as below: The ratio of CD8+ cells to immunosuppressive cells was increased in ~75% of patients suggesting an overall shift in the immune environment to pro-immune stimulatory following treatment with GEN-1.  This increase is believed to be a good predictor of b Show less Read more
Impact Snapshot
Event Time:
CLSN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CLSN alerts
Opt-in for
CLSN alerts

from News Quantified
Opt-in for
CLSN alerts

from News Quantified